**Core Concept**
In Acute Myeloid Leukemia (AML), cytogenetic abnormalities play a crucial role in determining prognosis and guiding treatment decisions. Cytogenetic abnormalities refer to changes in the number or structure of chromosomes, which can affect gene expression and protein function.

**Why the Correct Answer is Right**
Monosomy 7, also known as -7, is a deletion of one copy of chromosome 7. This abnormality is associated with a poor prognosis in AML patients due to its association with high-risk genetic features, such as mutations in the NPM1 and FLT3 genes. Monosomy 7 often leads to the loss of tumor suppressor genes and the inactivation of DNA repair mechanisms, resulting in a higher likelihood of treatment resistance and disease relapse.

**Why Each Wrong Option is Incorrect**
**Option B:** AML patients with no detectable cytogenetic abnormality (also known as normal cytogenetics) have an intermediate prognosis, which is generally better than those with high-risk cytogenetic abnormalities like monosomy 7.

**Option C:** The t(15;17) translocation is actually associated with a good prognosis in AML, particularly in patients with acute promyelocytic leukemia (APL). This translocation leads to the formation of the PML-RARA fusion gene, which can be effectively targeted with all-trans retinoic acid (ATRA) and arsenic trioxide.

**Option D:** The inv(16) inversion is associated with a good prognosis in AML, particularly in patients with the M4Eo subtype. This inversion leads to the formation of the CBFB-MYH11 fusion gene, which can be targeted with chemotherapy and supportive care.

**Clinical Pearl / High-Yield Fact**
In AML, cytogenetic abnormalities are a critical determinant of prognosis and treatment response. Patients with high-risk cytogenetic abnormalities, such as monosomy 7, require aggressive treatment strategies and may benefit from allogeneic stem cell transplantation.

**✓ Correct Answer: A. Monosomy 7**